Last updated on November 2017

Reveal


Brief description of study

Reveal

Detailed Study Description

Prospective, single arm, open-label, multicenter, post-market interventional clinical study to determine, via continuous monitoring with the Reveal XT implantable cardiac monitor (ICM), the incidence of atrial fibrillation (AF) in patients suspected to be at high risk for having AF and to understand how physicians manage these patients once AF has been detected.

Clinical Study Identifier: TX2185

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Adriana Valencia

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »